- MTR’s full-year revenue reached HK$60.01 billion, surpassing the estimated HK$58.54 billion.
- Revenue from Hong Kong Transport Operations was HK$23.01 billion, beating the forecast of HK$22.32 billion.
- Mainland China and International Subsidiaries generated HK$25.47 billion in revenue, exceeding the estimated HK$24.26 billion.
- Net income stood at HK$15.77 billion, outperforming the projected HK$13.92 billion.
- The company declared a final dividend of 89 HK cents per share.
- Underlying profit was reported at HK$17.48 billion, well above the prediction of HK$14.3 billion.
- Market analysts’ recommendations include 7 buys, 4 holds, and 2 sells.
“`
A look at MTR Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, MTR Corp, a company providing public transport services in Hong Kong and operating the Mass Transit Railway, has a solid overall outlook. With balanced scores in Value, Dividend, Growth, Resilience, and a slightly higher score in Momentum, MTR Corp seems to be positioned well for the long term. The company’s consistent performance across these key factors indicates a stable and potentially promising future.
MTR Corp‘s scores reflect a company that offers both growth potential and reliability in its operations. With a focus on providing public transport services and managing properties, MTR Corp‘s diverse business segments contribute to its overall positive outlook. Investors may find MTR Corp to be a well-rounded investment opportunity given its respectable scores across various important metrics.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
